Honoring a life scientist’s lifesaving science
Carl June accepted the 2024 Breakthrough Prize in Life Sciences at a Los Angeles ceremony, making him the sixth recipient from Penn.
News Archive
This Doctor Found His Own Miracle Drug. Now He Wants to Do It for Others
Dr. Fajgenbaum and his research on Castleman's disease featured in the Wall Street Journal
Unraveling the Complexities of BRCA-Related Breast and Ovarian Cancers
The BRCA1 (BReast CAncer gene 1) and BRCA2 are genes that produce proteins crucial for DNA repair. Women with inactivating mutations in BRCA genes face elevated lifetime risks of recurrent breast and ovarian cancers. Dr. Katherine L. Nathanson of the University of Pennsylvania discusses the complexities of BRCA related breast & ovarian cancers, ongoing research and the potential avenues for future breakthroughs.
Understanding Lecithin Cholesterol Acyltransferase (LCAT), Interview with Dr. Marina Cuchel
Dr. Marina Cuchel speaks about Lecithin Cholesterol Acyltransferase (LCAT) deficiency, a genetic disorder that affects the body’s ability to process cholesterol. It is characterized by cloudiness of the clear front surface of the eye (corneal opacities), a shortage of red blood cells (hemolytic anemia), and kidney failure.
AACI Clinical Research Innovation 2023 features seven submissions from ACC-CRU
AACI Clinical Research Innovation 2023 Abstracts and Posters book is now available featuring seven abstracts, posters from ACC-CRU Clinical Research Professionals
#ResearchOnResearch Professional Development Initiative for Clinical Research Professionals
An initiative developed at the ACC-CRU engages CRPs by encouraging them to develop proposals for projects aimed at improving the process of conducting clinical research.
Penn Medicine BioBank featured in Philadelphia Inquirer- Health
Link: Philadelphia Inquirer - Health (Penn Medicine BioBank) More than 260,000 people have signed up to participate in the project, called Penn Medicine BioBank,agreeing to have their samples stored in secure, negative-80 degree freezers. By cross-referencing participants’ DNA with their electronic health records,researchers have discovered genetic variants related to heart disease, hearing loss, diabetes, glaucoma, and muscular dystrophy, among other conditions.
Penn Medicine Clinical Research Nurses presented 9 sessions at Intl. Assoc. Clinical Research Nurses
IACRN held its annual conference in Philadelphia in 2023. 20 Clinical Research Nurses from Penn Medicine attended, and presented 9 sessions at the conference demonstrating their robust expertise in the field, represented Penn Medicine and networked with CRNs from around the world.
Susan Domchek, MD appears on NBC's "Today Show" to discuss vaccine in breast cancer
Susan Domchek, MD discusses the INO 5401 Vaccination in BRCA1/2 Mutation Carriers Study, which is testing an experimental vaccine to potentially prevent cancer for people with BRCA1 or BRCA2 mutations.
UPenn Opens New Multi-Disciplinary Research Labs
The Future of Medicine Rises in University City: University of Pennsylvania Opens New Multi-Disciplinary Research Labs in One uCity Square
Woman diagnosed with breast cancer at 34 credits clinical trial with saving her life-ABC News
Tune into Good Morning America on Monday, Oct. 2 to hear Kate and her doctors, including oncologist Hayley Knollman and breast surgeon Lola Fayanju, share her incredible story.
Penn Medicine Study Finds Wrist Temperature Associated With Future Risk of Disease
Findings indicate the potential for monitoring disease risk through inexpensive, unintrusive continuous measures of skin temperature
Katalin Karikó and Drew Weissman, Penn’s Historic mRNA Vaccine Research Team, Win 2023 Nobel Prize in Medicine
Highest Honor Bestowed for Foundational Discoveries that Gave the World a Vaccine to Fight COVID-19 Pandemic
Penn Medicine Lancaster General Health Research Institute
We strive to increase patient care options through new drugs and devices not yet available to the general public. We support investigators as they work to improve and advance medical care, while ensuring that all our research remains safe for patients and other study participants.